Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
Guardado en:
Autores principales: | Jean-Paul Guthmann, Francesco Checchi, Ingrid van den Broek, Suna Balkan, Michel van Herp, Eric Comte, Oscar Bernal, Jean-Marie Kindermans, Sarah Venis, Dominique Legros, Philippe J Guerin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5092d86b19441e9a731a11dae685d0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience.
por: Vincent Brown, et al.
Publicado: (2008) -
Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Médecins Sans Frontières.
por: Doris Schopper, et al.
Publicado: (2009) -
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
por: Freek de Haan, et al.
Publicado: (2021) - Médecine
-
High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
por: Hiroko Tsuruta, et al.
Publicado: (2009)